How Duffy Blood Group ( FY ) Polymorphism and Age Modulate Vivax Malaria Risk at the Community Level: A Population-based Retrospective Cohort Study in the Amazon
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf562 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Carlos A Prete und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Malaria, Vivax, Duffy Blood-Group System, Polymorphism, Genetic, Receptors, Cell Surface. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, National Institute of Allergy Infectious Diseases of the National Institutes of Health.
Abstract (Originalsprache)
Background
A promoter variant commonly found in sub-Saharan Africans and their descendants disrupts Duffy antigen (Fy) expression on erythrocytes, leading to the Fy-negative phenotype, and confers partial resistance to blood-stage Plasmodium vivax infection. In addition, the 125G→A substitution, rare in Africans, defines the Fya/Fyb polymorphism that can modulate vivax malaria risk in Amazonians. The combined effect of these FY polymorphisms on P. vivax infection risk remains little explored at the population level.
Methods
We studied a household-based random sample of 1737 Amazonians, with a well-balanced distribution of FY alleles, who were exposed to P. vivax transmission and contributed 7878.9 person-years of follow-up. We fitted a multivariable zero-inflated negative binomial model to incidence data, assuming that zero counts could arise from individuals at risk who remained uninfected over 5 years of follow-up (“sampling zeroes”) or from not-at-risk individuals (“structural zeroes”).
Results
Plasmodium vivax infections were heterogeneously distributed in the population, with 0 to 11 cases per person (average incidence, 25.8 cases/100 person-years at risk). We show that Fy-negativity remains a major malaria resistance trait in Amazonians and contributes significantly to the “structural zeroes” observed in P. vivax incidence data. Moreover, the differences in P. vivax infection risk associated with the Fya/Fyb polymorphism observed among young participants were attenuated with increasing age, most likely because more susceptible Fy(b+) individuals develop clinical immunity faster than less susceptible Fy(a+) individuals.
Conclusions
FY polymorphism appears to modulate the rate at which immunity to P. vivax develops in Amazonians, with clear clinical and public health implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
- Department of Communications, School of Electrical and Computer Engineering, State University of Campinas, Campinas, Brazil.
- Molecular Biology and Malaria Immunology Research Group, René Rachou Institute, Fiocruz, Belo Horizonte, Brazil.
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden.
- Brazilian Center for Research in Energy and Materials, Campinas, Brazil.
- Department of Demography, Institute of Philosophy and Humanities, State University of Campinas, Campinas, Brazil.
ORCID-Profile: Carlos A Prete, Taís N de Sousa, Maria Carolina S B Puça, Winni A Ladeia, Priscila T Rodrigues, Igor C Johansen, Gilberto A Paula, Marcelo U Ferreira, Rodrigo M Corder
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- National Institute of Allergy Infectious Diseases of the National Institutes of Health
- Fundação para a Ciência e Tecnologia
- Health-PDTIS FIOCRUZ
- Real-Time PCR Facility
- René Rachou Institute
- Eric and Wendy Schmidt AI
Zitieren
APA
Prete, C. A., de Sousa, T. N., Naziazeno, I. M., Puça, M. C. S. B., Ladeia, W. A., Rodrigues, P. T., Johansen, I. C., Paula, G. A., Ferreira, M. U., Corder, R. M., & Mâncio Lima Cohort Study Working Group (2025). How Duffy Blood Group ( FY ) Polymorphism and Age Modulate Vivax Malaria Risk at the Community Level: A Population-based Retrospective Cohort Study in the Amazon. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf562
Vancouver
Prete CA, de Sousa TN, Naziazeno IM, Puça MCSB, Ladeia WA, Rodrigues PT, et al. How Duffy Blood Group ( FY ) Polymorphism and Age Modulate Vivax Malaria Risk at the Community Level: A Population-based Retrospective Cohort Study in the Amazon. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf562
BibTeX
@article{Prete2025,
author = {Prete, Carlos A and de Sousa, Taís N and Naziazeno, Isabela M and Puça, Maria Carolina S B and Ladeia, Winni A and Rodrigues, Priscila T and Johansen, Igor C and Paula, Gilberto A and Ferreira, Marcelo U and Corder, Rodrigo M and Mâncio Lima Cohort Study Working Group, Mâncio Lima Cohort Study Working Group},
title = {How Duffy Blood Group ( FY ) Polymorphism and Age Modulate Vivax Malaria Risk at the Community Level: A Population-based Retrospective Cohort Study in the Amazon},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf562}
}
EUVIMED